Photo:

Neurology

Neural networks are emblematic of complex systems, so it's no surprise that the field of neurology is eclectic and intricate, too. Main challenges for neurologists are therapies of and research on stroke, seizures, movement disorders such as Parkinson's disease, autoimmune disorders such as multiple sclerosis and dementias such as Alzheimer's disease.

Photo

News • Research suggests wide range of applications

Exploring the therapeutic potential of ultrasound on the brain

New research suggests that transcranial ultrasound stimulation (TUS) could be used to help people with pain, alcoholism, OCD, and Parkinson’s disease, without drugs or surgery.

Photo

News • New frontiers in imaging

First MRI in Antarctica to study brains in space

Magnetic resonance imaging (MRI) has made the jump to the Antarctic continent. A new mobile scanner at the Concordia research station is used to study effects on the brain even further away: in space.

Photo

News • Cerebral venous sinus thrombosis

New score to predict epilepsy after CVT stroke

Cerebral venous sinus thrombosis (CVT) is a type of stroke that typically affects women between 20 and 50. Researchers developed a way to predict which patients are at risk of epilepsy after a CVT.

Photo

News • From silent to destructive

Exploring the two phases of Alzheimer's disease

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools.

Photo

Sponsored • Innovation in action

Taipei showcases cutting-edge medical devices & diagnostics at Medica 2024

Taipei City is set to make a splash at the Medica 2024 trade fair. The city's Department of Economic Development has curated an exhibition area, featuring six innovative biotech companies.

Photo

News • Neurodegenerative diseases

Tauopathy or Alzheimer's? Biomarker and PET imaging for improved diagnosis

Researchers have identified biomarkers that, in conjunction with PET imaging, enable doctors to reliably distinguish between primary 4-repeat tauopathies and Alzheimer's disease.

501 show more articles
Subscribe to Newsletter